Jazz Pharmaceuticals plc — Director's Dealing 2010

Sep 10, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2010-09-08

Reporting Person: MYERS ROBERT M (Director, President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-09-08	Common Stock	P	6000	$9.76	Acquired	152206	Direct